SCHEMBL11971402

SCHEMBL11971402

CCc1nc(O)c(Cc2cccc(Br)c2)c2cc(OC)c(OC)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 10/20 0.41
PDE4D Q08499 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 1/20 0.39
COL1A1 P02452 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
PLK4 O00444 1/20 0.38
CHEK1 O14757 1/20 0.38
AURKA O14965 1/20 0.38
NTRK1 P04629 1/20 0.38
LCK P06239 1/20 0.38
CDK1 P06493 1/20 0.38
CSF1R P07333 1/20 0.38
PIM1 P11309 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CDK2 P24941 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11971681 0.85 PDE10A (0.58) PDE10APDE4DALDH1A1KDM4EMAPT
Hydrochloric Acid SCHEMBL11971426 0.84 PDE10A (0.57) PDE10APDE4DALDH1A1KDM4EMAPT
SCHEMBL11971941 0.82 PDE10A (0.60) PDE10APDE4D
SCHEMBL11971986 0.82 PDE10A (0.60) PDE10APDE4DALDH1A1KDM4EMAPT
SCHEMBL11971865 0.82 PDE10A (0.60) PDE10APDE4DALDH1A1KDM4EMAPT
Hydrochloric Acid SCHEMBL11971501 0.81 PDE10A (0.59) PDE10APDE4DALDH1A1KDM4EMAPT
Hydrochloric Acid SCHEMBL11971430 0.81 PDE10A (0.59) PDE10APDE4DALDH1A1KDM4EMAPT
Hydrochloric Acid SCHEMBL11971522 0.81 PDE10A (0.59) PDE10APDE4D
SCHEMBL11971662 0.77 PDE10A (0.65) PDE10APDE4DSMN1; SMN2ALDH1A1KDM4E
SCHEMBL11971877 0.77 PDE10A (0.64) PDE10APDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670181-B2 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) ALLERGAN, INC. (US) 2017-06-06 US disclosed
US-9670181-B2 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) ALLERGAN, INC. (US) 2017-06-06 US disclosed
US-9670181-B2 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) ALLERGAN, INC. (US) 2017-06-06 US disclosed
EP-2675791-B1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A) ALLERGAN INC (US) 2016-02-17 EP disclosed
EP-2675791-B1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A) ALLERGAN INC (US) 2016-02-17 EP disclosed
US-20140309253-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A) ALLERGAN, INC. 2014-10-16 US disclosed
US-20140309253-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A) ALLERGAN, INC. 2014-10-16 US disclosed
US-20140309253-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A) ALLERGAN, INC. 2014-10-16 US disclosed
US-8772316-B2 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) ALLERGAN, INC. (US) 2014-07-08 US disclosed
US-8772316-B2 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) ALLERGAN, INC. (US) 2014-07-08 US disclosed
US-8772316-B2 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) ALLERGAN, INC. (US) 2014-07-08 US disclosed
EP-2675791-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A) Allergan, Inc. (US) 2013-12-25 EP disclosed
CN-103476757-A Substituted 6, 7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10(PDE10A) ALLERGAN INC 2013-12-25 CN disclosed
WO-2012112946-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A) ALLERGAN, INC. (US) 2012-08-23 WO disclosed
US-20120214837-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A) EXONHIT THERAPEUTICS SA (FR) 2012-08-23 US disclosed
US-20120214837-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A) EXONHIT THERAPEUTICS SA (FR) 2012-08-23 US disclosed
US-20120214837-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A) EXONHIT THERAPEUTICS SA (FR) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140309253-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A) PDE10A, PDE6A, PDE9A PDE10A 1/4885PDE4D 20/4885ADORA2A 470/4885
US-20120214837-A1 SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A) PDE10A, PDE6A, PDE9A PDE10A 1/4885PDE4D 22/4885ADORA2A 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.